GO:0052829 inositol-1,3,4-trisphosphate 1-phosphatase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0052829 defines the molecular function that removes the 1-phosphate from D-myo-inositol 1,3,4-trisphosphate to produce myo-inositol 3,4-bisphosphate and free phosphate.
• The enzyme responsible, inositol polyphosphate 1-phosphatase, was purified from calf brain and is inhibited by lithium, calcium and manganese ions.
• Its catalytic mechanism depends on magnesium and is blocked noncompetitively by lithium, making it a target for mood-stabilizer research.
• The bovine cDNA was cloned and expressed heterologously, enabling structural and functional studies.
• The crystal structure at 2.3 A resolution revealed the fold and active-site architecture of the enzyme.
• Dysregulation of inositol phosphate signaling is linked to bipolar disorder, cancer and metabolic disease, making this activity a focus of CRISPR model development.
Description
Inositol-1,3,4-trisphosphate 1-phosphatase activity (GO:0052829) is a molecular function that catalyzes the hydrolysis of D-myo-inositol 1,3,4-trisphosphate to myo-inositol 3,4-bisphosphate and phosphate. This reaction is part of the complex inositol phosphate signaling network that regulates cellular calcium homeostasis, vesicle trafficking and nuclear processes. The enzyme was first purified from calf brain and shown to be a magnesium-dependent phosphatase inhibited by lithium, calcium and manganese. Subsequent cloning of the bovine cDNA allowed heterologous expression and detailed kinetic analysis. The 2.3 A crystal structure of inositol polyphosphate 1-phosphatase provided the first atomic view of the enzyme, revealing a two-domain architecture with a catalytic core that binds inositol phosphates. Because lithium is a widely used mood stabilizer and its therapeutic effect may partly depend on inhibition of inositol phosphatases, this activity has attracted interest in neuropsychiatric research. In addition, inositol polyphosphates are involved in DNA repair, chromatin remodeling and cell cycle control, so understanding this enzyme's specificity and regulation is relevant to cancer biology and drug discovery. Researchers studying GO:0052829 need reliable tools to manipulate the encoding gene, measure its enzymatic activity and assess downstream inositol phosphate levels. This article summarizes the authoritative QuickGO definition, the biochemical mechanism, key genes and experimental models, and how CRISPR-based approaches can be used to dissect this activity in human cells.
inositol-1,3,4-trisphosphate 1-phosphatase activity At A Glance
| GO ID | GO:0052829 |
|---|---|
| GO term | inositol-1,3,4-trisphosphate 1-phosphatase activity |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Catalyzes the hydrolysis of D-myo-inositol 1,3,4-trisphosphate to myo-inositol 3,4-bisphosphate and phosphate |
| Reaction | D-myo-inositol 1,3,4-trisphosphate + H2O = myo-inositol 3,4-bisphosphate + phosphate |
| Cofactor | Magnesium-dependent; inhibited by lithium, calcium and manganese |
| Enzyme | Inositol polyphosphate 1-phosphatase (encoded by IMPA1/IMPA2-related genes in mammals) |
| Structural fold | Two-domain architecture with a catalytic core; crystal structure at 2.3 A |
What Is GO:0052829?
GO:0052829 describes the catalysis of the reaction: D-myo-inositol 1,3,4-trisphosphate + H2O = myo-inositol 3,4-bisphosphate + phosphate. In other words, it is the enzymatic removal of the phosphate group attached to the 1-position of the inositol ring from inositol 1,3,4-trisphosphate, leaving inositol 3,4-bisphosphate and inorganic phosphate. This activity is a molecular function, not a biological process or cellular component, and it is carried out by inositol polyphosphate 1-phosphatase, a magnesium-dependent enzyme that can be inhibited by lithium and calcium.
Why Is inositol-1,3,4-trisphosphate 1-phosphatase activity Important in Cell Biology?
GO:0052829 is important because it controls the cellular levels of inositol 1,3,4-trisphosphate, a key intermediate in inositol phosphate signaling that influences calcium release, membrane trafficking and nuclear functions. The enzyme's sensitivity to lithium links it directly to the mechanism of mood stabilizers used in bipolar disorder. Its magnesium dependence and inhibition by calcium and manganese make it a sensitive node for cellular stress and metal toxicity. Because inositol polyphosphates participate in DNA repair and chromatin regulation, altered activity of this enzyme may contribute to cancer and developmental disorders. Understanding this activity therefore has implications for neuropsychiatry, oncology and cell biology, and it provides a tractable target for CRISPR-based functional studies.
• Regulates inositol phosphate pools that affect calcium signaling and vesicle trafficking.
• Is inhibited by lithium, a first-line treatment for bipolar disorder, suggesting a role in mood stabilization.
• Requires magnesium and is inhibited by calcium and manganese, linking it to metal homeostasis.
• Its crystal structure provides a template for designing selective inhibitors.
• The bovine cDNA was cloned, enabling heterologous expression and mutagenesis.
• Inositol polyphosphates are involved in DNA repair and chromatin remodeling, so this activity may influence genome stability.
• Altered inositol signaling has been observed in cancer and metabolic disease models.
• The enzyme is a potential drug target for neuropsychiatric and neurodegenerative conditions.
• CRISPR knockout of the encoding gene can reveal its contribution to cellular phenotypes.
• Measuring this activity requires specific assays that distinguish it from other inositol phosphatases.
Molecular Mechanism of inositol-1,3,4-trisphosphate 1-phosphatase activity
Substrate recognition and binding
In simple terms: The enzyme grabs inositol 1,3,4-trisphosphate and positions it so that the 1-phosphate can be removed.
Inositol polyphosphate 1-phosphatase specifically binds D-myo-inositol 1,3,4-trisphosphate. The crystal structure at 2.3 A resolution revealed a two-domain protein with a positively charged active-site cleft that accommodates the inositol ring and its phosphate groups. The enzyme shows selectivity for the 1-position phosphate, distinguishing it from other inositol phosphatases.
Catalytic hydrolysis
In simple terms: A water molecule attacks the phosphate, breaking it off and releasing free phosphate.
The reaction catalyzed is D-myo-inositol 1,3,4-trisphosphate + H2O = myo-inositol 3,4-bisphosphate + phosphate. The enzyme is magnesium-dependent, and the metal ion likely stabilizes the leaving group and activates the water nucleophile. Kinetic studies of the purified calf brain enzyme showed that the reaction follows a sequential mechanism and is inhibited by lithium noncompetitively.
Cofactors and metal dependence
In simple terms: Magnesium helps the enzyme work, while calcium and manganese can block it.
Inositol polyphosphate 1-phosphatase requires magnesium for activity. It is inhibited by calcium and manganese ions, which may compete with magnesium or bind to regulatory sites. Lithium also inhibits the enzyme, and this inhibition is noncompetitive with respect to the substrate. These metal sensitivities suggest that the enzyme integrates cellular metal status into inositol phosphate signaling.
Structural determinants of specificity
In simple terms: The 3D shape of the enzyme explains why it only cuts the 1-phosphate.
The 2.3 A crystal structure of inositol polyphosphate 1-phosphatase showed a fold distinct from other phosphatases, with a deep active-site pocket that positions the 1-phosphate for hydrolysis while excluding the 3- and 4-phosphates. This structural information provides a basis for understanding how mutations might alter substrate specificity or catalytic efficiency.
Regulation by lithium and cellular signals
In simple terms: Lithium and other signals can turn down this enzyme's activity.
Lithium inhibits inositol polyphosphate 1-phosphatase in a noncompetitive manner, which may contribute to its therapeutic effects in bipolar disorder. The enzyme's activity can also be modulated by calcium and manganese, linking it to cellular signaling and stress responses. Hormone-sensitive inositol lipid pools with rapid turnover may influence substrate availability for this enzyme.
Key Genes Involved in GO:0052829 inositol-1,3,4-trisphosphate 1-phosphatase activity
The following genes and proteins are directly or indirectly involved in inositol-1,3,4-trisphosphate 1-phosphatase activity, based on published biochemical and structural studies.
| Gene | Major Role | Research Relevance |
|---|---|---|
| IMPA1 | Encodes inositol monophosphatase 1, involved in inositol phosphate metabolism | May regulate substrate availability for GO:0052829 |
| IMPA2 | Encodes inositol monophosphatase 2, a related phosphatase | Potential compensatory or regulatory role in inositol signaling |
| ITPK1 | Inositol-tetrakisphosphate 1-kinase, produces inositol polyphosphates | Upstream of inositol 1,3,4-trisphosphate production |
| IPPK | Inositol-pentakisphosphate 2-kinase, involved in inositol phosphate synthesis | May influence substrate pools for GO:0052829 |
| PLC-beta | Phospholipase C beta, generates inositol trisphosphates | Provides substrate for the enzyme |
| PLC-gamma | Phospholipase C gamma, generates inositol trisphosphates | Links growth factor signaling to inositol phosphate pools |
| INPP1 | Inositol polyphosphate 1-phosphatase, the enzyme for GO:0052829 | Directly catalyzes the reaction |
| INPP4A | Inositol polyphosphate 4-phosphatase, acts on different inositol phosphates | Related enzyme with distinct specificity |
| INPP5A | Inositol polyphosphate 5-phosphatase, acts on different inositol phosphates | Related enzyme with distinct specificity |
| ITPKA | Inositol-trisphosphate 3-kinase A, phosphorylates inositol trisphosphate | Competes with the phosphatase for substrate |
| ITPKB | Inositol-trisphosphate 3-kinase B, phosphorylates inositol trisphosphate | Regulates inositol phosphate flux |
| ITPKC | Inositol-trisphosphate 3-kinase C, phosphorylates inositol trisphosphate | Modulates substrate availability |
| CALM1 | Calmodulin, calcium sensor | Calcium inhibits the enzyme, calmodulin may mediate calcium effects |
| GRM1 | Metabotropic glutamate receptor 1, activates phospholipase C | Hormone-sensitive inositol lipid turnover |
| HTR2A | Serotonin receptor 2A, activates phospholipase C | Links neurotransmitter signaling to inositol phosphates |
| ADRB2 | Beta-2 adrenergic receptor, activates phospholipase C | Hormone-sensitive inositol lipid pool |
| MAG | Myelin-associated glycoprotein, not directly related | Listed as a negative control for specificity |
How Is inositol-1,3,4-trisphosphate 1-phosphatase activity Regulated?
Inositol-1,3,4-trisphosphate 1-phosphatase activity is regulated by metal ions and lithium. Magnesium is required for catalysis, while calcium and manganese inhibit the enzyme. Lithium acts as a noncompetitive inhibitor, reducing the enzyme's ability to hydrolyze inositol 1,3,4-trisphosphate. Hormone-sensitive inositol lipid pools with rapid turnover can affect substrate availability, linking receptor signaling to enzyme activity. Additionally, the enzyme's expression and activity may be influenced by cellular stress and developmental cues, though specific transcriptional regulators have not been fully defined in the cited literature.
inositol-1,3,4-trisphosphate 1-phosphatase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| INPP1 | Bipolar disorder, lithium response | Knockout or point-mutation cell lines to test lithium sensitivity |
| INPP1 | Cancer cell proliferation | Overexpression and knockout in cancer cell lines |
| INPP1 | Metal-induced neurotoxicity | Knock-in of metal-binding site mutations |
| IMPA1 | Inositol metabolism disorders | Knockout models to assess substrate availability |
| ITPKA | Inositol phosphate signaling in cancer | CRISPR knockout to measure inositol phosphate flux |
Bipolar disorder and mood stabilization
Lithium is a first-line treatment for bipolar disorder, and its therapeutic effect may involve inhibition of inositol polyphosphate 1-phosphatase, the enzyme responsible for GO:0052829. By reducing the breakdown of inositol 1,3,4-trisphosphate, lithium could alter downstream calcium signaling and neuronal excitability. This hypothesis has driven research into inositol phosphate metabolism as a target for mood stabilizers.
Cancer and cell proliferation
Inositol polyphosphates are involved in DNA repair, chromatin remodeling and cell cycle control, and altered inositol phosphate signaling has been observed in cancer models. The enzyme's activity could influence tumor cell survival by modulating these processes. However, direct evidence linking GO:0052829 to specific cancers remains limited in the cited literature.
Neurodegeneration and metal toxicity
The enzyme is inhibited by calcium and manganese, metals implicated in neurodegenerative conditions. Dysregulation of inositol phosphate signaling may contribute to neuronal dysfunction under metal stress. Further studies are needed to establish causal links between GO:0052829 and neurodegeneration.
From inositol-1,3,4-trisphosphate 1-phosphatase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of INPP1 alter inositol phosphate levels? | CRISPR knockout cell line |
| How does lithium inhibit the enzyme? | Point mutation of active-site residues |
| Can a disease-associated mutation affect catalysis? | Knock-in of patient variants |
| Where is the enzyme localized in cells? | Tagged knock-in with fluorescent protein |
| Does overexpression change calcium signaling? | Overexpression cell line |
| Which genes compensate for INPP1 loss? | CRISPR library screening |
How to Study the inositol-1,3,4-trisphosphate 1-phosphatase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled substrate assay | Enzymatic release of phosphate | Kinetic analysis of INPP1 |
| HPLC or TLC | Separation of inositol phosphates | Substrate and product quantification |
| X-ray crystallography | Three-dimensional protein structure | Active-site mapping |
| Site-directed mutagenesis | Effect of amino acid changes on activity | Mechanistic studies |
| CRISPR knockout | Loss-of-function phenotype | Gene function in cells |
| qPCR and western blot | mRNA and protein levels | Validation of knockout or overexpression |
| Mass spectrometry | Inositol phosphate species | Metabolic profiling |
| [14C]/[3H]inositol labeling | Turnover of inositol lipids | Hormone-sensitive pool analysis |
Enzymatic activity assays
Inositol-1,3,4-trisphosphate 1-phosphatase activity can be measured using radiolabeled substrate and thin-layer chromatography or high-performance liquid chromatography to separate inositol phosphates. These assays require magnesium and are sensitive to lithium, calcium and manganese, so buffer conditions must be controlled.
Structural biology
X-ray crystallography at 2.3 A resolution revealed the three-dimensional structure of inositol polyphosphate 1-phosphatase, providing insights into substrate binding and catalysis. Site-directed mutagenesis based on the structure can test the roles of active-site residues.
Gene expression and knockout studies
The bovine cDNA was cloned and expressed heterologously, enabling functional studies in mammalian cells. CRISPR knockout of the encoding gene can reveal cellular phenotypes and compensatory pathways. Quantitative PCR and western blotting can confirm loss of expression.
Inositol phosphate profiling
Mass spectrometry or radiolabeling with [14C]inositol and [3H]inositol can profile inositol phosphate pools and assess the impact of enzyme manipulation. These methods help link GO:0052829 activity to cellular signaling networks.
How CRISPR Can Be Used to Study GO:0052829 inositol-1,3,4-trisphosphate 1-phosphatase activity
Knockout
CRISPR knockout of the gene encoding inositol polyphosphate 1-phosphatase (INPP1) can eliminate GO:0052829 activity, allowing researchers to measure changes in inositol phosphate pools and downstream calcium signaling. Knockout cell lines are useful for testing lithium sensitivity and identifying compensatory pathways.
Point Mutation
Point mutations in the active site of INPP1 can be introduced by CRISPR to test the roles of specific residues in catalysis and metal binding, based on the crystal structure. Such mutants can distinguish substrate binding from hydrolysis and reveal how disease-associated variants affect enzyme function.
Knock-in
Knock-in of tagged or patient-derived variants of INPP1 allows precise measurement of enzyme localization, stability and activity in a physiological context. Fluorescent tags can be used to track the enzyme in live cells and correlate its distribution with inositol phosphate signaling.
Overexpression
Overexpression of INPP1 can increase GO:0052829 activity, reducing inositol 1,3,4-trisphosphate levels and altering downstream signaling. This approach is useful for testing whether excess enzyme activity protects against or exacerbates disease phenotypes.
How EDITGENE Supports inositol-1,3,4-trisphosphate 1-phosphatase activity Research
Researchers studying inositol-1,3,4-trisphosphate 1-phosphatase activity-related genes often need to determine whether a candidate gene is causally involved in a phenotype, how mutations affect enzyme function, and which pathways compensate for loss of activity. EDITGENE provides CRISPR-based cell models and screening services to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for inositol-1,3,4-trisphosphate 1-phosphatase activity research.
Frequently Asked Questions About inositol-1,3,4-trisphosphate 1-phosphatase activity
What is inositol-1,3,4-trisphosphate 1-phosphatase activity?
It is a molecular function (GO:0052829) that catalyzes the removal of the 1-phosphate from D-myo-inositol 1,3,4-trisphosphate to produce myo-inositol 3,4-bisphosphate and phosphate.
What genes are involved in inositol-1,3,4-trisphosphate 1-phosphatase activity?
The enzyme is encoded by INPP1 in mammals; related genes include IMPA1, IMPA2, ITPK1 and IPPK, which regulate inositol phosphate pools.
What is the reaction catalyzed by GO:0052829?
D-myo-inositol 1,3,4-trisphosphate + H2O = myo-inositol 3,4-bisphosphate + phosphate.
How is inositol-1,3,4-trisphosphate 1-phosphatase activity regulated?
It requires magnesium and is inhibited by lithium, calcium and manganese.
Why is lithium relevant to this enzyme?
Lithium noncompetitively inhibits inositol polyphosphate 1-phosphatase, which may contribute to its mood-stabilizing effects in bipolar disorder.
What diseases are linked to inositol-1,3,4-trisphosphate 1-phosphatase activity?
Bipolar disorder, cancer and metal-induced neurotoxicity have been associated with altered inositol phosphate signaling.
How can I study GO:0052829 in the lab?
Enzymatic assays with radiolabeled substrate, structural biology, CRISPR knockout and inositol phosphate profiling are common approaches.
What is the crystal structure of inositol polyphosphate 1-phosphatase?
The structure was solved at 2.3 A resolution, revealing a two-domain fold with a catalytic active site.
Can CRISPR be used to model inositol-1,3,4-trisphosphate 1-phosphatase activity?
Yes, CRISPR knockout, point mutation, knock-in and overexpression models can be used to dissect the function of INPP1 and related genes.
What services does EDITGENE offer for this target?
EDITGENE provides knockout, point-mutation, knock-in, overexpression cell models, CRISPR library screening and bioinformatics services for inositol phosphate research.
Conclusion
GO:0052829, inositol-1,3,4-trisphosphate 1-phosphatase activity, is a well-defined molecular function with a clear biochemical reaction and a characterized enzyme. Its sensitivity to lithium and metals links it to neuropsychiatric and metabolic research, while its role in inositol phosphate signaling connects it to cancer and cell biology. CRISPR-based models offer powerful tools to test causality and identify therapeutic opportunities. EDITGENE supports these efforts with tailored cell models and screening services.
References
- 1. York JD et al.. 1994. Crystal structure of inositol polyphosphate 1-phosphatase at 2.3-A resolution.. Biochemistry 33(45):13164-71 PMID: 7947723
- 2. Inhorn RC et al.. 1988. Properties of inositol polyphosphate 1-phosphatase.. J Biol Chem 263(28):14559-65 PMID: 2844776
- 3. Inhorn RC et al.. 1987. Inositol polyphosphate 1-phosphatase from calf brain. Purification and inhibition by Li+, Ca2+, and Mn2+.. J Biol Chem 262(33):15946-52 PMID: 2824473
- 4. York JD et al.. 1990. Isolation and heterologous expression of a cDNA encoding bovine inositol polyphosphate 1-phosphatase.. Proc Natl Acad Sci U S A 87(24):9548-52 PMID: 2175905
- 5. Pachter JA. 1991. Noncompetitive inhibition of inositol monophosphatase by K-76 monocarboxylic acid.. Mol Pharmacol 40(1):107-11 PMID: 1649963
- 6. Maccallum SH et al.. 1989. The use of cells doubly labelled with [14C]inositol and [3H]inositol to search for a hormone-sensitive inositol lipid pool with atypically rapid metabolic turnover.. J Endocrinol 122(1):379-89 PMID: 2769159
